Buprenorphine Tablet
Product Images NDC 0228-3153

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Buprenorphine (NDC 0228-3153). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

The Following Chemical Structure For Buprenorphine HCl, Usp Has The Molecular Formula C29 H41 No4 • HCl And The Molecular Weight Is 504.10. It Is A White Or Off-white Crystalline Powder, Sparingly Soluble In Water, Freely Soluble In Methanol, Soluble In Alcohol And Practically Insoluble In Cyclohexane. (Image 1)

Chemical structure diagram of Buprenorphine hydrochloride, showing the molecular arrangement including aromatic rings, hydroxyl groups, and a cyclopropylmethyl side chain.*

FDA Label Image

Tablets Debossed (Image 2)

The image shows a rectangular carton packaging of Buprenorphine sublingual tablets by Actavis Pharma, Inc. The label displays the proprietary name Buprenorphine and its strength of 8 mg per tablet. The front of the carton includes text indicating the dosage form as a sublingual tablet, along with other regulatory and manufacturer information.*

FDA Label Image

Tablets Debossed (Image 3)

Buprenorphine 8 mg sublingual tablet blister packaging with a clear plastic blister containing one tablet. The foil backing is silver with black text, showing the brand name Buprenorphine and dosage strength 8 mg. The labeler is Actavis Pharma, Inc. The image displays part of the tablet and packaging, highlighting the single-dose format.*

FDA Label Image

Small Image (Image 4)

An instructional illustration showing the placement of a sublingual tablet under the tongue. The image depicts a hand holding a tablet near the open mouth, demonstrating how to administer a sublingual dosage form.*

FDA Label Image

Principal Display Panel Ndc 0228-3156-03 Buprenorphine Sublingual Tablets 2 mg 30 Tablets Rx Only (Image 5)

Label for Buprenorphine Sublingual Tablets 2 mg by Actavis Pharma, Inc. The label indicates 30 tablets per container and provides storage and dispensing instructions, medication guide reference, and cautions about accidental ingestion. The label includes NDC 0228-3156-03 with a barcode and is marked as Schedule III.*

FDA Label Image

Principal Display Panel Ndc 0228-3153-03 Buprenorphine Sublingual Tablets 8 mg 30 Tablets Rx Only (Image 6)

Label for Buprenorphine Sublingual Tablets, 8 mg strength, in a 30 tablet package. The label shows the drug name, strength, National Drug Code (NDC 0228-3153-03), storage instructions, and manufacturing details by Teva Pharmaceuticals. It includes a barcode and warnings about dispensing medication guides and keeping out of reach of children.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.